Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis (2011)
- Authors:
- USP affiliated authors: LANCHOTE, VERA LUCIA - FCFRP ; TAKAYANAGUI, OSVALDO MASSAITI - FMRP ; BONATO, PIERINA SUELI - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1111/j.1365-2125.2011.03945.x
- Subjects: FARMACOCINÉTICA; ANTIPARASITÁRIOS; CISTICERCOSE (TRATAMENTO)
- Language: Inglês
- Imprenta:
- Source:
- Título: British Journal of Clinical Pharmacology
- ISSN: 0306-5251
- Volume/Número/Paginação/Ano: v. 72, n. 1, p. 77-84, 2011
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
GARCIA, Hector H. et al. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. British Journal of Clinical Pharmacology, v. 72, n. 1, p. 77-84, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2011.03945.x. Acesso em: 08 abr. 2026. -
APA
Garcia, H. H., Lescano, A. G., Lanchote, V. L., Pretell, E. J., Gonzales, I., Bustos, J. A., et al. (2011). Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. British Journal of Clinical Pharmacology, 72( 1), 77-84. doi:10.1111/j.1365-2125.2011.03945.x -
NLM
Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, Takayanagui OM, Bonato PS, Horton J, Saavedra H, Gonzalez AE, Gilman RH. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis [Internet]. British Journal of Clinical Pharmacology. 2011 ; 72( 1): 77-84.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1111/j.1365-2125.2011.03945.x -
Vancouver
Garcia HH, Lescano AG, Lanchote VL, Pretell EJ, Gonzales I, Bustos JA, Takayanagui OM, Bonato PS, Horton J, Saavedra H, Gonzalez AE, Gilman RH. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis [Internet]. British Journal of Clinical Pharmacology. 2011 ; 72( 1): 77-84.[citado 2026 abr. 08 ] Available from: https://doi.org/10.1111/j.1365-2125.2011.03945.x - Medical management of neurocysticercosis
- Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma
- Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry
- Silmutaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma
- Análise do albendazol sulfóxido e albendazol sulfona em plasma empregando LC-MS/MS
- Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis
- Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis
- Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics
- Therapy for neurocysticercosis: pharmacokinetic interactions of (+)-albendazole sulfoxide with cimetidine and ranitidine
- Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
